[
  {
    "ts": "2026-02-10T13:00:00+00:00",
    "headline": "IQVIA and Duke Clinical Research Institute Announce Strategic Collaboration to Advance Clinical Research in Obesity and Related Conditions",
    "summary": "RESEARCH TRIANGLE PARK, N.C., February 10, 2026--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, and the Duke Clinical Research Institute (DCRI), one of the world’s largest academic clinical research organizations with extensive experience designing and operationally executing large, complex multi-center clinical trials, are pleased to announce their new collaboration to enh",
    "url": "https://finance.yahoo.com/news/iqvia-duke-clinical-research-institute-130000067.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "41d7a10f-d9dc-3ef3-ab4c-186f08cfcaea",
      "content": {
        "id": "41d7a10f-d9dc-3ef3-ab4c-186f08cfcaea",
        "contentType": "STORY",
        "title": "IQVIA and Duke Clinical Research Institute Announce Strategic Collaboration to Advance Clinical Research in Obesity and Related Conditions",
        "description": "",
        "summary": "RESEARCH TRIANGLE PARK, N.C., February 10, 2026--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, and the Duke Clinical Research Institute (DCRI), one of the world’s largest academic clinical research organizations with extensive experience designing and operationally executing large, complex multi-center clinical trials, are pleased to announce their new collaboration to enh",
        "pubDate": "2026-02-10T13:00:00Z",
        "displayTime": "2026-02-10T13:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/35096c9ef97091138ce825285bb2a0ae",
          "originalWidth": 546,
          "originalHeight": 209,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/brB3PzcpvWemdLoYhKyHpQ--~B/aD0yMDk7dz01NDY7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/35096c9ef97091138ce825285bb2a0ae.cf.webp",
              "width": 546,
              "height": 209,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/mWjx5UR6AnSZrP5VSSF6Ng--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/35096c9ef97091138ce825285bb2a0ae.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/iqvia-duke-clinical-research-institute-130000067.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/iqvia-duke-clinical-research-institute-130000067.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "IQV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]